Evaluating the Safety and Efficacy of the Maurora® DES in ICAS
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 156 participants.
Also called NCT05719883
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 156 participants
- Sponsor
- Registry
-
NCT05719883
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT05719883. Randomized; single masking; primary purpose treatment. Start 2023-02-20 (actual); primary completion 2025-04-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluating the Safety and Efficacy of the Maurora® DES in ICAS
- Acronym
- Maurora ICAS
- Condition
- Intracranial Arteriosclerosis
- Condition
- Stroke (CVA) or TIA (transient ischemic attack)
- Intervention (Device)
- Maurora® Sirolimus Eluting Stent System
- Intervention (Device)
- APOLLO™ Intracranial Stent System
- Lead sponsor
- Beijing Tiantan Hospital
- Collaborator
- Alain Medical (Beijing) Co., Ltd.
Record details
- Record id
cardio:ct-nct05719883- Content hash
14a740be332f88cff6b12c4cb56a5262ed28906dfcc6b0e2021e82819c467520